Fundamental Analysis of XOS INC(NASDAQ:XOS) stock

Fundamental Rating

Overall XOS gets a fundamental rating of 3 out of 10. We evaluated XOS against 132 industry peers in the Machinery industry. XOS scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. XOS is valued quite expensively, but it does show have an excellent growth rating.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year XOS has reported negative net income.

In the past year XOS has reported a negative cash flow from operations.

XOS had negative earnings in 4 of the past 5 years.

XOS had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

The Return On Assets of XOS (-80.96%) is worse than 90.70% of its industry peers.

The Return On Equity of XOS (-167.82%) is worse than 91.47% of its industry peers.

		Industry Rank	Sector Rank
ROA	-80.96%
ROE	-167.82%
ROIC	N/A

ROA(3y)-36.45%

ROA(5y)-81.24%

ROE(3y)-73.27%

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

XOS does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

XOS does not have a ROIC to compare to the WACC, probably because it is not profitable.

Compared to 1 year ago, XOS has less shares outstanding

The number of shares outstanding for XOS has been reduced compared to 5 years ago.

Compared to 1 year ago, XOS has an improved debt to assets ratio.

2.2 Solvency

XOS has an Altman-Z score of -2.70. This is a bad value and indicates that XOS is not financially healthy and even has some risk of bankruptcy.

Looking at the Altman-Z score, with a value of -2.70, XOS is doing worse than 85.27% of the companies in the same industry.

XOS has a Debt/Equity ratio of 0.47. This is a healthy value indicating a solid balance between debt and equity.

Looking at the Debt to Equity ratio, with a value of 0.47, XOS is in line with its industry, outperforming 45.74% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	0.47
Debt/FCF	N/A
Altman-Z	-2.7

ROIC/WACCN/A

WACC8.3%

2.3 Liquidity

XOS has a Current Ratio of 3.66. This indicates that XOS is financially healthy and has no problem in meeting its short term obligations.

XOS has a Current ratio of 3.66. This is amongst the best in the industry. XOS outperforms 84.50% of its industry peers.

A Quick Ratio of 1.73 indicates that XOS should not have too much problems paying its short term obligations.

XOS has a better Quick ratio (1.73) than 72.87% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	3.66
Quick Ratio	1.73

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

XOS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -232.41%.

The Revenue has grown by 22.39% in the past year. This is a very strong growth!

The Revenue has been growing by 170.05% on average over the past years. This is a very strong growth!

EPS 1Y (TTM)-232.41%

EPS 3YN/A

EPS 5YN/A

EPS growth Q2Q35.28%

Revenue 1Y (TTM)22.39%

Revenue growth 3Y156.45%

Revenue growth 5Y170.05%

Revenue growth Q2Q114.42%

3.2 Future

Based on estimates for the next years, XOS will show a very strong growth in Earnings Per Share. The EPS will grow by 27.43% on average per year.

Based on estimates for the next years, XOS will show a very strong growth in Revenue. The Revenue will grow by 91.75% on average per year.

EPS Next Y38.69%

EPS Next 2Y27.43%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year95.66%

Revenue Next 2Y91.75%

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

XOS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for XOS. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as XOS's earnings are expected to grow with 27.43% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y27.43%

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

XOS does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

XOS INC

NASDAQ:XOS (5/3/2024, 3:00:00 PM)

7.45

-0.2 (-2.61%)

Chartmill FA Rating

GICS SectorIndustrials

GICS IndustryGroupCapital Goods

GICS IndustryMachinery

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap57.74M

Analysts

Price Target

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Dividend Growth(5Y)

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA

EPS(TTM)

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-80.96%
ROE	-167.82%
ROCE
ROIC
ROICexc
ROICexgc
OM	N/A
PM (TTM)	N/A
GM	N/A
FCFM

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.48

Health

		Industry Rank	Sector Rank
Debt/Equity	0.47
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio	3.66
Quick Ratio	1.73
Altman-Z

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

Growth

EPS 1Y (TTM)-232.41%

EPS 3YN/A

EPS 5Y

EPS growth Q2Q

EPS Next Y38.69%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)22.39%

Revenue growth 3Y156.45%

Revenue growth 5Y

Revenue growth Q2Q

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y

XOS INC (XOS)

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens